DE EN
DE EN
Home
News

Press releases

Latest News

Symbolic image
Smart Biomarkers to Empower Drug Development for Brain Diseases
Dresden Researchers Awarded Prestigious Funding by the Helmholtz Association to Validate a Novel Approach that Combines Neuroelectronics and Artificial Intelligence.
Symbol image, not for editorial use.
Alzheimer’s: U.S. Regulatory Authority Approves Use of “Aducanumab” on the Condition of Further Studies
Statement by Prof. Pierluigi Nicotera, Scientific Director and Chairman of the DZNE’s Executive Board.
Cover of “Nature”
AI with Swarm Intelligence
Publication in „Nature“: Researchers led by DZNE analyze medical data with a novel artificial intelligence technology. Collaboration with Hewlett Packard Enterprise.
Symbol image
Studies on “Long COVID”
DZNE researchers look into the long-term effects of an infection with the coronavirus.
Symbol image
Better care for people with dementia at home: Ambulatory care specialists take over medical tasks for the first time
The DZNE is leading a study project in which specialists in geriatric and nursing care are being specifically further qualified.
Symbol image shows foods that are typical of the Mediterranean diet
DZNE Alzheimer's study: A Mediterranean diet might protect against memory loss and dementia
This diet which contains fish, vegetables and olive oil, may slow brain aging.
Symbol image shows antibodies and coronaviruses.
SARS-CoV-2: New Findings on the Persistence of Neutralizing Antibodies
Data from the “Rhineland Study” in Bonn, Germany.
Symbolic image of a nerve cell.
Experimental gene regulation therapy lowers levels of Tau protein in the brain and could protect against Alzheimer's
A research group involving the DZNE has successfully developed a new method of gene regulation that permanently reduces the protein "tau" in the adult brain. This could become the basis for new therapies against Alzheimer's and other neurodegenerative diseases. …
his microscopic image shows networks of neurons as they typically develop in 3D cell cultures.
DZNE’s First Spin-off “Neuron–D” Uses Innovative Technology for Drug Testing
Drug screening with 3D cell cultures.
Logo Eisai
DZNE and Eisai Enter Into Research Collaboration Agreement
The DZNE and Eisai Co., Ltd. announce that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders.

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: 
Imprint |Data Protection